Genital Diseases, Female  >>  Zejula (niraparib)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zejula (niraparib) / GSK, J&J
MK-4827-001, NCT00749502: A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies ( AM8)

Checkmark In BRCA mutation carriers & pts with sporadic cancer
Jul 2013 - Jul 2013: In BRCA mutation carriers & pts with sporadic cancer
Checkmark Final results in ovarian cancer at ASCO 2013
May 2013 - Jun 2013: Final results in ovarian cancer at ASCO 2013
Checkmark In ovarian cancer at ASCO 2011
More
Completed
1
113
US
MK-4827
Tesaro, Inc.
Solid Tumors, Chronic Lymphocytic Leukemia, T-cell-prolymphocytic Leukemia
09/11
06/13
NCT01227941: MK-4827 in Combination With Pegylated Liposomal Doxorubicin in Participants With Advanced Solid Tumors and Ovarian Cancer (MK-4827-011)

Terminated
1
6
US
MK-4827 + pegylated liposomal doxorubicin, Doxil, Caelyx
Tesaro, Inc.
Ovarian Cancer
09/11
09/11

Download Options